Holen Sie sich die Stockscreener-App
2.04
5.70%
0.11
Schlusskurs vom Vortag:
$1.93
Offen:
$1.95
24-Stunden-Volumen:
91,509
Relative Volume:
0.70
Marktkapitalisierung:
$256.15M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-63.68M
KGV:
-3.9231
EPS:
-0.52
Netto-Cashflow:
$-54.15M
1W Leistung:
+9.68%
1M Leistung:
+15.91%
6M Leistung:
-21.84%
1J Leistung:
-32.23%
1-Tages-Spanne:
$1.95
$2.11
1-Wochen-Bereich:
$1.885
$2.11
52-Wochen-Spanne:
$1.61
$3.12
Nautilus Biotechnology Inc Stock (NAUT) Company Profile
Firmenname
Nautilus Biotechnology Inc
Sektor
Branche
Telefon
206-333-2001
Adresse
2701 EASTLAKE AVE EAST, SEATTLE
Vergleichen Sie NAUT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NAUT
Nautilus Biotechnology Inc
|
2.04 | 256.15M | 0 | -63.68M | -54.15M | -0.52 |
|
VRTX
Vertex Pharmaceuticals Inc
|
427.89 | 110.19B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
687.80 | 75.58B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
647.39 | 38.71B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
264.99 | 34.18B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.25 | 28.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Nautilus Biotechnology Inc Stock (NAUT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-05 | Herabstufung | Goldman | Neutral → Sell |
| 2024-06-27 | Eingeleitet | Guggenheim | Buy |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
| 2022-01-06 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-11-02 | Eingeleitet | Cowen | Outperform |
| 2021-08-04 | Eingeleitet | Goldman | Neutral |
| 2021-07-13 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Nautilus Biotechnology Inc Aktie (NAUT) Neueste Nachrichten
Barclays PLC Buys 47,059 Shares of Nautilus Biotechnology, Inc. (NASDAQ:NAUT) - Defense World
Jeff Bezos Stock Portfolio: Top Investment Picks - CoinCodex
Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Short Interest Down 14.2% in December - MarketBeat
Barclays PLC Has $1.04 Million Holdings in Northfield Bancorp, Inc. (Staten Island, NY) (NASDAQ:NFBK) - Defense World
Jane Street Group LLC Sells 25,020 Shares of Nautilus Biotechnology, Inc. (NASDAQ:NAUT) - Defense World
US Penny Stocks To Watch In January 2025 - Simply Wall St
Dermata Therapeutics Inc (DRMA): Major Improvements, Worth A Look - Stocks Register
Barclays PLC Has $303,000 Stock Holdings in Nautilus Biotechnology, Inc. (NASDAQ:NAUT) - Defense World
State Street Corp Lowers Holdings in Nautilus Biotechnology, Inc. (NASDAQ:NAUT) - Defense World
The Manufacturers Life Insurance Company Invests $67,000 in Nautilus Biotechnology, Inc. (NASDAQ:NAUT) - Defense World
US Penny Stocks Spotlight: Information Services Group Among 3 Top Picks - Simply Wall St
With 32% ownership, Nautilus Biotechnology, Inc. (NASDAQ:NAUT) insiders have a lot riding on the company's future - Yahoo Finance
Nautilus Biotechnology (NASDAQ:NAUT) Cut to “Sell” at The Goldman Sachs Group - Defense World
Goldman Sachs Downgrades Nautilus Biotechnology (NAUT) - MSN
Goldman Sachs cuts Nautilus Biotechnology stock to sell By Investing.com - Investing.com Canada
Goldman Sachs cuts Nautilus Biotechnology stock to sell - Investing.com
Nautilus Biotechnology Inc (NAUT-Q) QuotePress Release - The Globe and Mail
Nautilus Biotechnology Reports Q3 2024 Financial Results - MSN
Nautilus Biotechnology (NASDAQ:NAUT) Stock Price Up 0.8% – Here’s What Happened - Defense World
Nautilus Biotechnology (NASDAQ:NAUT) Shares Up 0.8%What's Next? - MarketBeat
3 US Penny Stocks With Market Caps Up To $400M - Simply Wall St
Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with the Academy for Radiology and Biomedical Imaging Research’s Distinguished Investigator Award - BioSpace
Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with the Academy for Radiology and Biomedical Imaging Research's Distinguished Investigator Award - Quantisnow
Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Q3 2024 Earnings Call Transcript - Insider Monkey
Nautilus Biotechnology Co-founder and Chief Scientist Parag - GlobeNewswire
Nautilus Biotechnology Faces ESG Challenges Amid Regulatory Pressure and Investor Scrutiny - TipRanks
Glass House Brands to Host Third Quarter 2024 Conference Call on November 13, 2024 - The Manila Times
Nautilus Biotechnology to Participate in the Inaugural Guggenheim Healthcare Conference - GlobeNewswire
SG Americas Securities LLC Takes Position in Cardlytics, Inc. (NASDAQ:CDLX) - Defense World
Nautilus Biotechnology Reports Third Quarter 2024 Financial Results - GlobeNewswire
Nautilus Biotechnology reports Q3 EPS (13c), consensus (16c) - TipRanks
Nautilus Biotechnology (NAUT) Scheduled to Post Quarterly Earnings on Tuesday - MarketBeat
Renaissance Technologies LLC Decreases Stock Holdings in Immix Biopharma, Inc. (NASDAQ:IMMX) - Defense World
Renaissance Technologies LLC Acquires 9,459 Shares of Toro Corp. (NASDAQ:TORO) - Defense World
Renaissance Technologies LLC Has $358,000 Stock Holdings in Standard Lithium Ltd. (NYSE:SLI) - Defense World
Renaissance Technologies LLC Cuts Stock Holdings in OPKO Health, Inc. (NASDAQ:OPK) - Defense World
Nautilus Biotechnology Inc. - Scrip
We Think Nautilus Biotechnology (NASDAQ:NAUT) Can Afford To Drive Business Growth - Yahoo Finance
Nautilus Biotechnology to Announce Third Quarter 2024 Financial Results on October 29, 2024 - The Manila Times
nautilus biotechnology, inc. Earnings dates - RTTNews
Clearline Capital LP Lowers Stake in Nautilus Biotechnology, Inc. (NASDAQ:NAUT) - Defense World
Tech Moves: GE healthcare exec joins startup; Nautilus taps new CMO; WRF investor steps down - MSN
Insider Selling: Nautilus Biotechnology, Inc. (NASDAQ:NAUT) VP Sells 47,031 Shares of Stock - Defense World
Nautilus Biotechnology senior VP sells over $134k in company stock - Investing.com
Caxton Associates LP Acquires 131,589 Shares of Entegris, Inc. (NASDAQ:ENTG) - Defense World
2 Kite vets fly over to Kyverna Therapeutics—Chutes & Ladders - Fierce Biotech
Nautilus Biotechnology senior VP sells shares worth over $99k - Investing.com India
Nautilus Biotechnology senior VP sells shares worth over $99k By Investing.com - Investing.com Canada
Finanzdaten der Nautilus Biotechnology Inc-Aktie (NAUT)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.81%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):